(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.35%) $91.45
Live Chart Being Loaded With Signals
Jacobson Pharma Corporation Limited, through its subsidiaries, produces, markets, and sells generic drugs and branded healthcare products in Hong Kong, Mainland China, Macau, Singapore, and internationally...
Stats | |
---|---|
今日成交量 | 320 000 |
平均成交量 | 541 484 |
市值 | 1.13B |
EPS | HKD0.0272 ( 2023-06-15 ) |
Last Dividend | HKD0.0238 ( 2023-08-15 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | 5.18 |
ATR14 | HKD0 (0.00%) |
Jacobson Pharma 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Jacobson Pharma 财务报表
Annual | 2022 |
营收: | HKD1.79B |
毛利润: | HKD747.17M (41.84 %) |
EPS: | HKD0.130 |
FY | 2022 |
营收: | HKD1.79B |
毛利润: | HKD747.17M (41.84 %) |
EPS: | HKD0.130 |
FY | 2022 |
营收: | HKD1.60B |
毛利润: | HKD620.52M (38.89 %) |
EPS: | HKD0.0927 |
FY | 2021 |
营收: | HKD1.45B |
毛利润: | HKD561.08M (38.80 %) |
EPS: | HKD0.0900 |
Financial Reports:
No articles found.
Jacobson Pharma Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0 (N/A) |
HKD0.0548 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0.0238 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.00800 | 2017-01-09 |
Last Dividend | HKD0.0238 | 2023-08-15 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 14 | -- |
Total Paid Out | HKD0.264 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.52 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 4.45 | |
Div. Directional Score | 7.93 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
2338.HK | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
1310.HK | Ex Dividend Junior | 2023-05-16 | Semi-Annually | 0 | 0.00% | |
0366.HK | Ex Dividend Knight | 2023-09-25 | Semi-Annually | 0 | 0.00% | |
6186.HK | Ex Dividend Knight | 2023-09-07 | Semi-Annually | 0 | 0.00% | |
1866.HK | Ex Dividend Junior | 2023-06-06 | Annually | 0 | 0.00% | |
0887.HK | Ex Dividend Knight | 2023-09-07 | Annually | 0 | 0.00% | |
0026.HK | Ex Dividend Junior | 2023-10-03 | Semi-Annually | 0 | 0.00% | |
2722.HK | Ex Dividend Junior | 2023-06-26 | Annually | 0 | 0.00% | |
1443.HK | Ex Dividend Junior | 2023-10-04 | Annually | 0 | 0.00% | |
0522.HK | Ex Dividend Junior | 2023-08-14 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.143 | 1.500 | 7.14 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0604 | 1.200 | 7.99 | 9.59 | [0 - 0.3] |
returnOnEquityTTM | 0.0959 | 1.500 | -0.0452 | -0.0679 | [0.1 - 1] |
payoutRatioTTM | 0.621 | -1.000 | 3.79 | -3.79 | [0 - 1] |
currentRatioTTM | 1.283 | 0.800 | 8.58 | 6.87 | [1 - 3] |
quickRatioTTM | 1.009 | 0.800 | 8.77 | 7.01 | [0.8 - 2.5] |
cashRatioTTM | 0.788 | 1.500 | 6.73 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.329 | -1.500 | 4.52 | -6.79 | [0 - 0.6] |
interestCoverageTTM | 3.30 | 1.000 | 9.89 | 9.89 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.330 | 2.00 | 9.89 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.271 | 2.00 | 9.86 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.574 | -1.500 | 7.70 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.421 | 1.000 | 6.32 | 6.32 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.182 | 1.000 | 8.37 | 8.37 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.482 | 1.000 | 8.43 | 8.43 | [0.2 - 2] |
assetTurnoverTTM | 0.422 | 0.800 | -0.519 | -0.415 | [0.5 - 2] |
Total Score | 11.41 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 4.53 | 1.000 | 9.64 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0959 | 2.50 | -0.0291 | -0.0679 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.271 | 2.00 | 9.91 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 8.56 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.330 | 2.00 | 9.89 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.621 | 1.500 | 3.79 | -3.79 | [0 - 1] |
pegRatioTTM | 0.112 | 1.500 | -2.58 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.375 | 1.000 | 3.12 | 0 | [0.1 - 0.5] |
Total Score | 4.45 |
Jacobson Pharma
Jacobson Pharma Corporation Limited, through its subsidiaries, produces, markets, and sells generic drugs and branded healthcare products in Hong Kong, Mainland China, Macau, Singapore, and internationally. The company offers generic drugs for various therapeutic categories, including the respiratory, cardiovascular, central nervous system, gastrointestinal, genito-urinary, musculoskeletal, endocrine and metabolic, dermatological, anti-allergics, scar treatment, oral anti-diabetics, and anti-infective, as well as arsenic trioxide oral solutions, rosuvastatin tablets, and atorvastatin tablets. It also provides branded medicines; health and wellness products; and proprietary Chinese medicines, such as Po Chai pills, Ho Chai Kung Tji Thung San, Tong Tai Chung Woodlok oil, Flying Eagle Woodlok Oil, Saplingtan, Shiling oil, Contractubex, Doan's Ointment, and Col-gan tablets. In addition, it engages in the trading of medical supplies; procurement of packaging materials; sale of healthcare and herbal products; research and development; and property holding activities. Jacobson Pharma Corporation Limited sells its products to hospitals and clinics, and registered pharmacies, as well as to doctors in private and retail outlets, and trading companies. The company was incorporated in 2016 and is headquartered in Kwun Tong, Hong Kong. Jacobson Pharma Corporation Limited is a subsidiary of Kingshill Development Limited.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。